Seeking Alpha

Stemline Therapeutics (STML)

There is research on this stock available only to PRO subscribers.
From other sites
STML vs. ETF Alternatives
Company Description
Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, acquiring, developing and commercializing proprietary therapeutics that target both cancer stem cells, or CSCs, and tumor bulk.